![]() |
|
|
Vol. 15, Issue 6, 2627-2638, June 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Wales Heart Research Institute, Department of Cardiology, University of Wales College of Medicine, Cardiff, United Kingdom CF14 4XN;
National Heart and Lung Institute, Imperial College of Science Technology and Medicine, London, United Kingdom SW3 6LY
Submitted September 24, 2003;
Revised March 2, 2004;
Accepted March 17, 2004
Monitoring Editor: Suzanne Pfeffer
Ryanodine receptors (RyR) function as Ca2+ channels that regulate Ca2+ release from intracellular stores to control a diverse array of cellular processes. The massive cytoplasmic domain of RyR is believed to be responsible for regulating channel function. We investigated interaction between the transmembrane Ca2+-releasing pore and a panel of cytoplasmic domains of the human cardiac RyR in living cells. Expression of eGFP-tagged RyR constructs encoding distinct transmembrane topological models profoundly altered intracellular Ca2+ handling and was refractory to modulation by ryanodine, FKBP12.6 and caffeine. The impact of coexpressing dsRed-tagged cytoplasmic domains of RyR2 on intracellular Ca2+ phenotype was assessed using confocal microscopy coupled with parallel determination of in situ protein: protein interaction using fluorescence resonance energy transfer (FRET). Dynamic interactions between RyR cytoplasmic and transmembrane domains were mediated by amino acids 3722-4610 (Interacting or "I"-domain) which critically modulated intracellular Ca2+ handling and restored RyR sensitivity to caffeine activation. These results provide compelling evidence that specific interaction between cytoplasmic and transmembrane domains is an important mechanism in the intrinsic modulation of RyR Ca2+ release channels.
Corresponding author. E-mail address: georgech{at}cf.ac.uk.
This article has been cited by other articles:
![]() |
S. Sedej, F. R. Heinzel, S. Walther, N. Dybkova, P. Wakula, J. Groborz, P. Gronau, L. S. Maier, M. A. Vos, F. Anthony Lai, et al. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation Cardiovasc Res, February 4, 2010; (2010) cvq007v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tateishi, M. Yano, M. Mochizuki, T. Suetomi, M. Ono, X. Xu, H. Uchinoumi, S. Okuda, T. Oda, S. Kobayashi, et al. Defective domain-domain interactions within the ryanodine receptor as a critical cause of diastolic Ca2+ leak in failing hearts Cardiovasc Res, February 15, 2009; 81(3): 536 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fernandez-Velasco, A. Rueda, N. Rizzi, J.-P. Benitah, B. Colombi, C. Napolitano, S. G. Priori, S. Richard, and A. M. Gomez Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia Circ. Res., January 30, 2009; 104(2): 201 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Meur, A. K. T. Parker, F. V. Gergely, and C. W. Taylor Targeting and Retention of Type 1 Ryanodine Receptors to the Endoplasmic Reticulum J. Biol. Chem., August 10, 2007; 282(32): 23096 - 23103. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. George, S. A. Rogers, B. M.A. Bertrand, R. E.A. Tunwell, N. L. Thomas, D. S. Steele, E. V. Cox, C. Pepper, C. J. Hazeel, W. C. Claycomb, et al. Alternative Splicing of Ryanodine Receptors Modulates Cardiomyocyte Ca2+ Signaling and Susceptibility to Apoptosis Circ. Res., March 30, 2007; 100(6): 874 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rossi, P. De Smet, A. Lyfenko, L. Galli, S. Lorenzini, D. Franci, F. Petrioli, A. Orrico, C. Angelini, V. Tegazzin, et al. A truncation in the RYR1 gene associated with central core lesions in skeletal muscle fibres J. Med. Genet., February 1, 2007; 44(2): e67 - e67. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Fessenden, W. Feng, I. N. Pessah, and P. D. Allen Amino Acid Residues Gln4020 and Lys4021 of the Ryanodine Receptor Type 1 Are Required for Activation by 4-Chloro-m-cresol J. Biol. Chem., July 28, 2006; 281(30): 21022 - 21031. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Y. Yi, V. X. Li, F. Zhang, F. Yi, D. R. Matson, M. T. Jiang, and P.-L. Li Characteristics and actions of NAD(P)H oxidase on the sarcoplasmic reticulum of coronary artery smooth muscle Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1136 - H1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. George, H. Jundi, N. Walters, N. L. Thomas, R. R. West, and F. A. Lai Arrhythmogenic Mutation-Linked Defects in Ryanodine Receptor Autoregulation Reveal a Novel Mechanism of Ca2+ Release Channel Dysfunction Circ. Res., January 6, 2006; 98(1): 88 - 97. [Abstract] [Full Text] [PDF] |
||||